Clinical Trial Update: Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial of combination chemotherapy for patients with myelodysplastic syndromes, sponsored by ALZA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: ALZA | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN